Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cohort of Repeat Donor Experiences (CORE) Study
Sponsor: Westat
Summary
The Plasma Protein Therapeutics Association (PPTA) sponsors the Cohort of Repeat Donor Experiences (CORE) Study. This is a prospective, observational cohort study that will follow Source Plasma donors for up to 2 years during the main study (launching in October 2026) ) and up to 3 months during the pilot inconducted April - September 2026. This study aims to confirm a lack of negative health effects Source Plasma donors may experience as a result of frequent plasmapheresis. The study will use data obtained through self-report surveys for the duration of the study along with periodic whole blood sample collections to test for CRP, ferritin, and IgG.
Key Details
Gender
All
Age Range
18 Years - 74 Years
Study Type
OBSERVATIONAL
Enrollment
2400
Start Date
2026-10
Completion Date
2029-04-30
Last Updated
2026-10-19
Healthy Volunteers
No
Conditions
Interventions
Plasmapheresis Procedure
Both pilot and main cohort will undergo plasmapheresis (plasma donation) as part of their initial visit for the study. Some participants will donate plasma throughout the duration of either cohort (3 months in pilot or up to 2 years in the main study.
Locations (12)
Takeda BioLife
Tempe, Arizona, United States
LFB Plasma
Pueblo, Colorado, United States
Kedplasma
Cocoa, Florida, United States
Takeda BioLife
Ammon, Idaho, United States
Grifols Biomat
Merrillville, Indiana, United States
Takeda BioLife
West Des Moines, Iowa, United States
Grifols Biomat
Wichita, Kansas, United States
Kedplasma
Bowling Green, Kentucky, United States
Takeda BioLife
Salisbury, Maryland, United States
Takeda BioLife
West Springfield, Massachusetts, United States
Kedplasma
El Paso, Texas, United States
Grifols Biomat
Humble, Texas, United States